Coronary revascularisation in young adults
OBJECTIVE: To evaluate the long-term outcome of coronary artery bypasssurgery (CABG) in patients < 40 years old and to determine factorspredictive of adverse outcomes. METHODS: Retrospective review of data on220 patients who underwent isolated CABG at Green Lane Hospital, NewZealand from 1970 to...
Saved in:
Published in: | European journal of cardio-thoracic surgery Vol. 11; no. 4; pp. 732 - 738 |
---|---|
Main Authors: | , , , , , , , |
Format: | Journal Article |
Language: | English |
Published: |
Amsterdam
Elsevier Science B.V
01-04-1997
Elsevier Science |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | OBJECTIVE: To evaluate the long-term outcome of coronary artery bypasssurgery (CABG) in patients < 40 years old and to determine factorspredictive of adverse outcomes. METHODS: Retrospective review of data on220 patients who underwent isolated CABG at Green Lane Hospital, NewZealand from 1970 to 1992. RESULTS: The actuarial survival after surgerywas 91, 74 and 50% at 5, 10 and 15 years, respectively. Recurrence ofischaemic symptoms occurred at a median time of 72 months, and only 20% ofpatients remained asymptomatic 10 years after CABG. Univariate analysis ofpotentially adverse surgical factors showed that patients who had prolongedbypass time (> or = 100 min, P < 0.007) had increased late mortality.There were two distinct operative eras with respect to the use of IMAconduits (4% pre 1985, 87% post 1984) The relationship between IMA conduitsuse and survival was significant on time independent analysis (P <0.02), but was not using the log-rank test. Preoperative clinicalcharacteristics associated with increased late mortality were impaired leftventricular function (end-systolic volume (ESV) > or = 80 ml, P = 0.008;ejection fraction < 40%, P = 0.0005), and lack of aspirin use eitherpre- or post- operatively (P < 0.0001). Multivariate analysis indicatedthat reduced ejection fraction (P = 0.04) and prolonged bypass time (P =0.05) was associated with an increased risk of late death. Aspirin therapy(P = 0.001) was associated with decreased late mortality. Cumulative eventsrate of reintervention and mortality was reduced in female patients (P =0.0009). At review, 45% of patients had total cholesterol > 6.5 mmol/l.CONCLUSION: To avoid the early recurrence of symptoms, the need forreintervention and late mortality, young patients should receive IMAconduits, cardioplegia as myocardial protection, aspirin and therapy tomodify/ameliorate their risk factors including dyslipidaemia, diabetes andleft ventricular dysfunction. |
---|---|
Bibliography: | ark:/67375/HXZ-ZJ60BN3Q-4 istex:D3BC13019323396AF639177279AB0F5F3C4E7D9F ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 1010-7940 1873-734X |
DOI: | 10.1016/S1010-7940(97)01153-6 |